ArticlePDF Available

Laparoscopic Vertical Clip Gastroplasty – Quality of life

Authors:
  • Phi Medcare
  • Clinique Saint Michel, Toulon, France
  • Independent Researcher

Abstract and Figures

Background Over the last decade, several techniques have emerged and the bariatric trends have changed. A new bariatric procedure that has been proposed is laparoscopic vertical clip gastroplasty (LVCG), which mimics the principle of laparoscopic sleeve gastrectomy, but with a completely reversible mechanism. The introduction of a new procedure in the bariatric armamentarium necessitated a period of preclinical and clinical studies and a validation of the procedure concerning the quality of life. Setting Private hospital, Dominican Republic. Objectives The purpose of this manuscript was to evaluate patient satisfaction, measured by various questionnaires after LVCG. Methods From November 2012 to February 2017, 138 patients underwent LVCG and demographic data were collected prospectively. A total of 82 were evaluated for quality of life with a minimum follow-up of 6 months after the procedure. The quality of life was also analyzed regarding the complications and resolution of different medical conditions included in the Bariatric Analysis and Reporting Outcome System score. Results Eighty-five patients (73.9%) agreed to participate in the study and a total of 82 patients completed the questionnaires at all points in time. Seventy-one patients were female, with an average age of 34 (19–38). Mean body mass index before operation was 42.4 kg/m² and declined significantly in both the first and second year postoperatively to 33.7 kg/m² (1-year follow-up) in 65 patients and 34.3 kg/m² (2-year follow-up) in 37 patients. The results showed failure for 1.2% of patients and were fair for 6.1% of cases. Quality of life was assessed as good for 26 patients (31.8%), as very good for 39 patients (47.5%), and as excellent for 11 patients (13.4%). Conclusions LVCG represents a new bariatric procedure that mimics the principle of laparoscopic sleeve gastrectomy, but with a completely reversible mechanism. The procedure consists of a nonadjustable clip that is vertically placed parallel to the lesser curvature. After >3 years of clinical use, the weight loss results seem to be encouraging and up to 92.7% of patients have an improved quality of life.
Content may be subject to copyright.
Surgery for Obesity and Related Diseases 14 (2018) 1587–1593
Original article
Laparoscopic vertical clip gastroplasty – quality of life
Patrick Noel
a , b
, Adrian Marius Nedelcu
b , , Imane Eddbali
a
, Natan Zundel
c
a
Emirates Specialty Hospital, 267 Oud Metha Road, Dubai, United Arab Emirates
b
ELSAN, Clinique Saint Michel, Centre Chirurgical de l’Obesite, Toulon, France
c
Herbert Wertheim College of Medicine, Florida International University, Miami, Florida
Received 16 March 2018; received in revised form 8 July 2018; accepted 16 July 2018
Abstract Background: Over the last decade, several techniques have emerged and the bariatric trends
have changed. A new bariatric procedure that has been proposed is laparoscopic vertical clip
gastroplasty (LVCG), which mimics the principle of laparoscopic sleeve gastrectomy, but with a
completely reversible mechanism. The introduction of a new procedure in the bariatric armamen-
tarium necessitated a period of preclinical and clinical studies and a validation of the procedure
concerning the quality of life.
Setting: Private hospital, Dominican Republic.
Objectives: The purpose of this manuscript was to evaluate patient satisfaction, measured by
various questionnaires after LVC G .
Methods: From November 2012 to February 2017, 138 patients underwent LVCG and demo-
graphic data were collected prospectively. A total of 82 were evaluated for quality of life with a
minimum follow-up of 6 months after the procedure. The quality of life was also analyzed re-
garding the complications and resolution of different medical conditions included in the Bariatric
Analysis and Reporting Outcome System score.
Results: Eighty-five patients (73.9%) agreed to participate in the study and a total of 82 patients
completed the questionnaires at all points in time. Seventy-one patients were female, with an
average age of 34 (19–38). Mean body mass index before operation was 42.4 kg/m
2 and declined
significantly in both the first and second year postoperatively to 33.7 kg/m
2 (1-year follow-up)
in 65 patients and 34.3 kg/m
2 (2-year follow-up) in 37 patients. The results showed failure for
1.2% of patients and were fair for 6.1% of cases. Quality of life was assessed as good for 26
patients (31.8%), as very good for 39 patients (47.5%), and as excellent for 11 patients (13.4%).
Conclusions: LVCG represents a new bariatric procedure that mimics the principle of laparo-
scopic sleeve gastrectomy, but with a completely reversible mechanism. The procedure consists
of a nonadjustable clip that is vertically placed parallel to the lesser curvature. After > 3 years of
clinical use, the weight loss results seem to be encouraging and up to 92.7% of patients have an
improved quality of life. (Surg Obes Relat Dis 2018;14:1587–1593.) © 2018 American Society
for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.
Keywords: Laparoscopic vertical clip gastroplasty; Reflux; Sleeve; Reversible
There is substantial evidence that surgery is the only
valid treatment for morbid obesity [1,2] . Over the last
decade, several techniques have emerged and bariatric
Correspondence: Adrian Marius Nedelcu, NEDELCU Clinique Saint
Michel – Avenue d’Orient, 83100 Toulon, France.
E-mail address: nedelcu.marius@gmail.com (A.M. Nedelcu).
trends have changed [3,4] . Presently, the most commonly
performed technique is laparoscopic sleeve gastrectomy
(LSG), after many years of laparoscopic Roux-en-Y gas-
tric bypass being considered the gold standard. This growth
can be explained by several advantages that LSG carries
over laparoscopic Roux-en-Y gastric bypass, including the
https://doi.org/10.1016/j.soard.2018.07.013
1550-7289/© 2018 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.
1588 Patrick Noel et al. / Surgery for Obesity and Related Diseases 14 (2018) 1587–1593
Tab l e 1
Demographic data.
Demographics Before surgery
Age 34
Sex Male 14%
Females 86%
Average BMI 42.4 (31.5–54.2)
BMI = body mass index.
absence of most side effects of bypass procedures such as
dumping syndrome, marginal ulcers, malabsorption, small
bowel obstruction, and internal hernia, allowing it to of-
fer a better quality of life (QoL) compared with gastric
banding [5] .
One of the main concerns for long-term results after
LSG is gastroesophageal reflux disease (GERD). Accord-
ing to several reports [6,7] , substantially more patients
were taking proton pump inhibitors for GERD late after
the procedure than before it. The data in the literature for
this issue, however, vary vastly [8] . Nevertheless, an inci-
dence of 21.4% for de novo GERD reported by Himpens
et al. [6] , in line with other series [9] , is a reason for
concern regarding an irreversible procedure like LSG, es-
pecially given the increased risk of evolution into Barrett’s
esophagus [10,11] .
Recently, a new bariatric procedure has been proposed:
laparoscopic vertical clip gastroplasty (LVCG) [12] , which
mimics the principle of LSG, but with a completely re-
versible mechanism. The procedure consists of a nonad-
justable clip that is vertically placed parallel to the lesser
curvature. The introduction of a new procedure in the
bariatric armamentarium necessitated a period of preclini-
cal and clinical studies and validation of the procedure con-
cerning QoL. Consequently, the purpose of this manuscript
is to evaluate patient satisfaction, measured by various
questionnaires.
Methods
From November 2012 to February 2017, 138 patients
underwent LVCG , and demographic data were collected
prospectively. A total of 82 were evaluated for QoL with
a minimum follow-up of 6 months after the procedure. De-
mographic data are summarized in Table 1 . The interroga-
tion was conducted by an independent investigator (P.N.),
who collected the data that were further independently an-
alyzed by another author (M.N.).
The score of Moorehead-Ardelt questionnaire [13] is
summarized in Fig. 1 . The Bariatric Analysis and Re-
porting Outcome System (BAROS) is a unique scoring
method to evaluate, in a single page, the results after
bariatric surgery. Points are added or deducted accord-
ing to weight loss, improvements in co-morbidities, and
changes in QOL. Points are deducted for complications
and reoperations, before yielding a final score that classi-
fies outcomes in the following 5 categories: failure, fair,
good, very good, and excellent. Weight evolution was an-
alyzed in terms of percentage of excess body mass index
(BMI) loss, calculated as (initial BMI – current BMI) /
(initial BMI – 25) ×100. Weight regain was scored with
1 point and different weight loss was scored as follows:
0% to 25% with 0 points; 25% to 50 % with 1 point; 50%
to 75% with 2 points; and > 75% with 3 points. The med-
ical co-morbidities were classified as follows: aggravated
(one point less), unchanged (0 points), improved (1 point),
1 major resolved (2 points), and > 1 morbidity resolved (3
points).
Surgical technique
The surgical technique of LVC G has been described and
published previously [12] . Briefly, the first step is to cre-
ate a small opening at the angle of His with an articulated
dissector, followed by a 3- to 4-cm window on the greater
curvature, directly inferior to the incisura angularis. The
articulated dissector is passed into the lesser sac to the left
of the left gastric vessels and articulated to 90 °, coming
out at the angle of His. The weight loss clip and its flex-
ible closing belt is then inserted through this window and
fixed to the stomach both anteriorly and posteriorly after
inserting a calibration tube similarly as with LSG. The clip
consists of a silicone-covered titanium backbone with an
inferior hinged opening that separates a medial lumen from
an excluded lateral gastric pouch. The inferior opening al-
lows the gastric juices to empty from the fundus and the
body of the stomach into the distal antrum ( Fig. 2 ). The
technique thus did not involve extensive dissection of the
hiatus.
Statistical analysis
The t test was used for the comparison of variation of
QoL score between the preoperative and postoperative test.
A t test’s statistical significance indicates whether the dif-
ference between 2 groups’ averages most likely reflects a
“real” difference in the population from which the groups
were sampled. The significance threshold was set for P <
.05.
Results
Between November 2012 and February 2017, 138 pa-
tients underwent LVCG . Upon consultation with the Eu-
ropean Union regulatory agencies, by protocol, 15 clips
were to be removed after different lengths of time of im-
plantation to prove reversibility. Eight other patients had
their clips removed for different complications that were
discussed in the previous report [12] . After clip removal,
Patrick Noel et al. / Surgery for Obesity and Related Diseases 14 (2018) 1587–1593 1589
Fig. 1. Moorehead-Ardelt questionnaire.
these patients were not included statistically. Of the re-
maining, 85 patients (73.9%) agreed to participate in the
study and a total of 82 patients completed the question-
naires at all different points in time. Seventy-one patients
were female with an average age of 34 (19–38) years.
Mean BMI before operation was 42.4 kg/m
2 and declined
significantly in both the first and second year postopera-
tively to 33.7 kg/m
2 (1-year follow-up) in 65 patients and
34.3 kg/m
2 (2-year follow-up) in 37 patients.
The analysis of the Moorhead-Ardelt Quality of Life
Questionnaire showed a significant improvement of the
scores for each of 6 dimensions. The variation of the scores
of QoL is significant ( P < .001). For item 1 (“I usually
feel…”), the QoL was improved by 181%, for item 2 (“I
enjoy physical activities”) by 262%, for item 3 (“I have
satisfactory social contacts”) by 69%, for item 4 (“I am
able to work”) by 19%, for item 5 (“The pleasure I get
out of sex”) by 41%, for item 6 (“The way I approach
1590 Patrick Noel et al. / Surgery for Obesity and Related Diseases 14 (2018) 1587–1593
Fig. 2. Laparoscopic vertical clip gastroplasty.
food is….”) by 418%. Each patient’s answers for each of
these 6 items are summarized in Figs. 3 and 4 .
The QoL was also analyzed regarding the complications
and resolution of different medical conditions included in
the BAROS Score. The results showed failure for 1.2% of
patients and were fair for 6.1% of cases. The QoL was
assessed as good for 26 patients (31.8%), as very good
for 39 patients (47.5%), and as excellent for 11 patients
(13.4%).
Discussion
The constant need to find a new bariatric operation rep-
resents a clear sign that all the current procedures have
certain limitations and complications. LSG became the
most common performed bariatric procedure probably be-
cause of its good ratio between complications and weight
loss results and its high popularity in social media. Still,
many surgeons implicate the LSG for 2 major disadvan-
tages: postoperative GERD and irreversibility. The LVC G
has the same restriction principle as LSG with a similar
gastric tube volume. It restricts oral intake with no need
of resection (requires no stapling), does not change gastric
anatomy (compared with LSG), causes no malabsorption
(compared with laparoscopic Roux-en-Y gastric bypass),
and does not require any adjustment (compared with la-
paroscopic adjustable gastric band [LAGB]).
Because reversibility is considered one of the main ad-
vantages of this new procedure (especially compared with
sleeve), particular attention was paid to the closing pres-
sure of the device during the preclinical studies.
The first gastric clip was developed in the 1980s without
any success, mainly because it was associated with com-
plications [14] . The rigidity of the device, its components,
and its oblique position at the upper part of the stomach
explained the high rate of obstruction and erosion at that
time. It was more an obstructive procedure than a restric-
tive one and was placed more like a nonadjustable gastric
band than a Bari Clip. Currently, the Bari Clip is designed
to minimize the closing force so that the limbs will sim-
ply oppose the anterior and posterior walls of the stom-
ach to minimize the possibility of erosions and ischemia.
The experience with the gastric band with the 2 different
techniques (pars flacida and perigastric) taught us a lesson
about gastric migration. Himpens et al. [15] reported a rate
up to 28% for band erosion with the perigastric technique.
Even if a further review [16] showed a decreased incidence
of band erosion with the modification to the pars flacida
Patrick Noel et al. / Surgery for Obesity and Related Diseases 14 (2018) 1587–1593 1591
Fig. 3. Items evolution of Moorehead-Ardelt questionnaire.
technique, this complication remains one of the inconve-
niences of the LAGB.
Up to 4 years, with LCSG, erosion was seen in 2 pa-
tients (1.4%), both located at the antrum of the stomach.
This was diagnosed 24 and 48 months postoperatively in
asymptomatic patients after being identified during routine
endoscopic surveillance. This complication was explained
after reviewing the recorded video. The reason for this
complication in the first patient was due to both the use
of a first-generation 13-cm clip instead of a 14.5-cm clip
and trauma to the antrum during placement. The gastric
clip was removed laparoscopically without complications.
For the second patient erosion was explained by chronic
slippage of the clip, which we chose at the time to manage
conservatively. We have since decided to change the man-
agement of the potential asymptomatic chronic slippage by
explanting or repositioning the clip.
The postoperative QoL after bariatric surgery is thought
to depend on the quantity of weight loss, resolution of
co-morbid medical conditions, improved function in daily
activities, and the absence of postoperative complications.
No reference standard yet exists for the assessment of
bariatric postoperative QoL. BAROS, introduced by Oria
and Moorehead in 1998 [13] , is an established and recog-
nized tool for QoL evaluation in people with obesity [17] .
BAROS QoL survey (incorporating the Moorehead-Ardelt
quality of life questionnaire) is simpler and more widely
used. We believe the BAROS survey might oversimplify
QoL assessment. Bobowicz et al. [18] used BAROS to
evaluate LSG outcomes in 84 patients 5 years after surgery.
An overall very good result was achieved in 30% of pa-
tients, whereas no effects were reported by 13% of respon-
dents. Similar or even greater results were recorded with
LCSG. For up to 60% of 82 patients, the QoL post-LVCG
was assessed as very good or excellent and no effect was
recorded for 7.3% of respondents. In the significant ma-
jority of the remaining group, the QoL was assessed as
average, corresponding to the general standard. Ribaric et
al. [19] presented a 3-year follow-up health-related QoL
on BAROS of patients operated on in France using the
Swedish adjustable gastric band method. The results were
evaluated in the preoperative period and 1, 3, 6, 12, 18,
24, and 36 months after surgery. It was found that weight
loss resulted in improved QoL over the 3 years of ob-
servation. The overall BAROS score increased from 1.4
preoperatively to 3.6 (2.2, P < .001) after 3 years. In our
study, the BAROS score improved from 1.08 (SD ±.96)
preoperatively to 5.34 (SD ±1.70) after LVC G . Our study
showed an important variation of the scores of the dimen-
sions “The way I approach food is….” and “physical ac-
tivity”, with mean increases of 418% and 262%, respec-
tively. They are the most important variations. On the phys-
ical plan, weight loss facilitates movement by decreasing
the handicap caused by the patient’s weight and volume.
The resumption of normal physical activities is facilitated.
The dimension “I am able to work…” was not strongly
modified in postoperative period, the score being increased
by only 19%.
1592 Patrick Noel et al. / Surgery for Obesity and Related Diseases 14 (2018) 1587–1593
Fig. 4. Quality of life items.
At the beginning of LSG, many surgeons were im-
pressed by the rapidity with which patients shifted toward
chosing LSG instead of LAGB, mainly due to the sig-
nificantly greater rates of vomiting in the LAGB groups
[5,20] . LCSG represents a new bariatric procedure with a
device implanted (more or less similar to LAGB), but our
results showed that the QoL results and vomiting episodes
(6.52%) are more similar to LSG. One of the limitations
of our study and of LVCG will be represented by the sur-
geon’s enthusiasm in offering a novel procedure that is
likely to influence some patients toward that procedure,
despite our best efforts (independent investigators) to pro-
vide impartial and evidence-based information. For this
reason, another multicenter prospective trial will start in
well-selected centers that subsequently will be involved in
the surgeons’ training for this new procedure ( Table 2 ).
Tab l e 2
Complications after LVC G.
Complication Rate Management
Slippage 6.52% (n = 9) 2 explanted, 2 revised,
5 treated conservatively
Erosion 1.44% (n = 2) Explanted
GERD 5% (n = 7) the first month
.72% (n = 1) after 1 mo
PPI
LVCG = laparoscopic vertical clip gastroplasty; GERD =
gastroesophageal reflux disease; PPI = proton pump inhibitors.
Postoperative gastroesophageal reflux
The lack of objective measurements such as pH-metry,
impedance, and high-resolution manometry does not pro-
vide robust evidence on the effects of LSG on GERD. The
Roux-en-Y gastric bypass represents the most common
Patrick Noel et al. / Surgery for Obesity and Related Diseases 14 (2018) 1587–1593 1593
option, especially for patients with severe gastroesophageal
reflux after LSG. Newer strategies like Stretta, Linx, or En-
dostim [21,22] need to be explored and could represent a
future alternative. To avoid GERD after LSG, a new pro-
cedure, N-sleeve [23] , was proposed, with the following
2 main limitations: incomplete gastric fundus removal and
difficult revisional procedures in case of weight regain or
recurrence of GERD. Compared with this, LVCG presents
complete exclusion of the gastric fundus. With its minimal
dissection of the hiatal region, a revisional procedure will
be less difficult, with decreased risk of complications.
Conclusion
LVCG represents a new bariatric procedure that mim-
ics the principle of LSG, but with a completely reversible
mechanism. The procedure consists of a nonadjustable clip
that is vertically placed parallel to the lesser curvature. Af-
ter > 3 years of clinical use, the weight loss results seem
to be encouraging, and up to 92.7% of patients report im-
proved QoL.
Disclosures
The authors have no commercial associations that might
be a conflict of interest in relation to this article .
References
[1] Fobi M . Surgical treatment of obesity: a review. J Natl Med Assoc
2004;96(1):61–75 .
[2] Tor ger s on JS , Sjöström L . The Swedish Obese Subjects (SOS) study:
rationale and results. Int J Obes Relat Metab Disord 2001;25(Suppl
1):S2–4 .
[3] Ponce J , DeMaria EJ , Nguyen NT , Hutter M , Sudan R , Morton JM .
American Society for Metabolic and Bariatric Surgery estimation of
bariatric surgery procedures in 2015 and surgeon workforce in the
United States. Surg Obes Relat Dis 2015;12(9):1637–9 .
[4] Lazzati A , Guy-Lachuer R , Delaunay V , Szwarcensztein K ,
Azoulay D . Bariatric surgery trends in France: 2005-2011. Surg
Obes Relat Dis 2014;10(2):328–34 .
[5] Fezzi M , Kolotkin RL , Nedelcu M , et al. Improvement in qual-
ity of life after laparoscopic sleeve gastrectomy. Obes Surg
2011(8):1161–7 .
[6] Himpens J , Dobbeleir J , Peeters G . Long-term results
of laparoscopic sleeve gastrectomy for obesity. Ann Surg
2010;252(2):319–24 .
[7] Noel P , Nedelcu M , Ed dbali I , Manos T , Gagner M . What are the
long-term results 8 years after sleeve gastrectomy? Surg Obes Relat
Dis 2017;13(7):110–15 .
[8] Chiu S , Birch DW , Shi X , et al. Impact of sleeve gastrectomy on
gastroesophageal reflux disease: a systematic review. Surg Obes Re-
lat Dis 2011;7(4):510–15 .
[9] Howard DD , Caban AM , Cendan JC , Ben-David K . Gastroe-
sophageal reflux after sleeve gastrectomy in morbidly obese patients.
Surg Obes Relat Dis 2011;7(6):709–13 .
[10] Genco A , Soricelli E , Casella G , et al. Gastroesophagal reflux dis-
ease and Barrett’s esophagus after laparoscopic sleeve gastrectomy:
a possible underestimated long-term complication. Surg Obes Relat
Dis 2017;13(4):568–74 .
[11] Felsenreich DM , Kefurt R , Schermann M , et al. Reflux, Sleeve dila-
tion, and Barrett’s esophagus after laparoscopic sleeve gastrectomy:
long-term follow-up. Obes Surg 2017;27(12):3092–101 .
[12] Jacobs M , Zundel N , Plasencia G , Rodriguez-Pumarol P , Gomez E ,
Leithead J 3rd . A vertically placed clip for weight loss: a 39-month
pilot study. Obes Surg 2017;27(5):1174–81 .
[13] Oria HE , Moorehead MK . Bariatric Analysis and Reporting Out-
come System (BAROS). Obes Surg 1998(5):487–99 .
[14] Chang CG , Provost DA . Gastro-clip gastroplasty: a very long-term
complication. Obes Surg 2004;14(1):136–8 .
[15] J1 Himpens , GB Cadière , Bazi M , Vouche M , Cadière B , Dapri G .
Long-term outcomes of laparoscopic adjustable gastric banding.
Arch Surg 2011;146(7):802–7 .
[16] Singhal R , Bryant C , Kitchen M , et al. Band slippage and ero-
sion after laparoscopic gastric banding: a meta-analysis. Surg En-
dosc 2010;24(12):2980–6 .
[17] Nini E , Slim K , Scesa JL , et al. Evaluation de la chirurgie
coelioscopique de l’obesite par le score BAROS. Ann Chir
2002;127(2):107–14 .
[18] Bobowicz M , Lehmann A , Orłowski M , et al. Preliminary outcomes
1 year after laparoscopic sleeve gastrectomy based on Bariatric
Analysis and Reporting Outcome System (BAROS). Obes Surg
2011(12):1843–8 .
[19] Ribaric G , Buchwald JN , d’Orsay , et al. 3-year-world outcomes with
the Swedish gastric band, in France. Obes Surg 2013(2):184–96 .
[20] Alley JB , Fenton SJ , Harnisch MC , Tapper DN , Pfluke JM , Pe-
terson RM . Quality of life after sleeve gastrectomy and adjustable
gastric banding. Surg Obes Relat Dis 2012(1):31–40 .
[21] Rebecchi F, Allaix ME, Patti MG, Schlottmann F, Morino M Gas-
troesophageal reflux disease and morbid obesity: to sleeve or not to
sleeve? Worl d J Gastroenterol 2017;23(13):2269–75.
[22] Desart K , Rossidis G , Michel M , Lux T , Ben-David K . Gastroe-
sophageal reflux management with the LINX® system for gastroe-
sophageal reflux disease following laparoscopic sleeve gastrectomy.
J Gastrointest Surg 2015;19(10):1782–6 .
[23] Nocca D , Skalli EM , Boulay E , Nedelcu M , Michel Fabre J ,
Loureiro M . Nissen Sleeve (N-Sleeve) operation: preliminary results
of a pilot study. Surg Obes Relat Dis 2016;12(10):1832–7 .
... The initial complications reported were erosion with an incidence of 1.4%, slippage of 6.52%, gastroesophageal reflux of 5% in the first month, and a decrease of 0.72% after the second month [2]. This study aims to report the experience of 3 years of a single bariatric surgical group, report 3 clinical cases of complications 1 from this group and 2 from a nonbariatric group, and do a literature review and a proposal for a definitive standardization of the technique. ...
... Jacobs et al. described a weight loss of up to 60% over 5 years and reported the following complications [3]: clip slippage, which occurred in 6-7.7% of cases, and erosions with an incidence of 1.4-2.6% [2,3]. ...
... The plan is to tackle these cases in two phases, with the first involving clip extraction from the gastric wall and the second involving a definitive derivative procedure. Authors have emphasized the significance of removing the BariClip in cases of complications such as intolerance, erosion, slippage, unsuccessful repositioning, and gastric obstructions [1][2][3][4][5][6][7]. In our experience, we have also removed clips for similar reasons. ...
Article
Full-text available
Laparoscopic vertical clip gastroplasty (LVCG) with BariClip is a recent procedure that appears to be safe Gentileschi et al. (Obes Surg 33(1):303-12, 2023). The initial complications reported include erosion, slippage, and gastroesophageal reflux. This study aimed to report on the experience of a single surgical group, analyzing three clinical cases, conducting a literature review, and proposing a standardization of the technique. A retrospective study was conducted with data from June 2021 to October 2024. We collected the data from the procedures related to the bariatric clip made by only one surgical group; we collected 69 cases with 1 complication of this surgical group. Additionally, we described 2 clinical cases of complications related to bariatric clips from other surgical institutions and reviewed the literature related to the BariClip experience. The results are related to the evaluation of the technique and compare the different modifications implemented over the last 3 years of follow-up. Furthermore, we aim to share our experience in attending to one of the most concerning complications associated with this procedure. The LVCG is a safe procedure with a low incidence of complications and positive results in %EWL. We propose several modifications to the original technique to further reduce complications, and we share the experience of both treating and resolving some of the complications we encountered.
... Placed as described, the laparoscopic BariClip gastroplasty (LBCG) will address a similar restriction with the LSG at the level of the gastric fundus, while remaining the advantage of simplicity and anatomic preservation. In addition, early data shows comparable early results to the gastric sleeve with less complications [6][7][8]. ...
... Our initial technique [6,8] involved simple placement of the clip with suture fixation of the BariClip silicone outer layer to the anterior and posterior gastric wall. It was then decided to add a gastro-gastric plication of the gastric wall covering the BariClip at those areas where the gastric wall "slips" through between the limbs of the clip. ...
... To overcome these limitations, Jacobs et al. [6] have proposed the laparoscopic BariClip gastroplasty (LBCG) as the alternative. In previous study [8], we reported that LBCG offers acceptable weight loss and improvement in the quality of life with the same principles as LSG while offering several distinct advantages. There is no risk of leakage. ...
Article
Full-text available
Introduction: Laparoscopic BariClip gastroplasty (LBCG) will address a similar tubular restriction than the one achieved with the laparoscopic sleeve gastrectomy (LSG) at the level of the gastric fundus, while maintaining the advantage of simplicity and anatomic preservation. The purpose of the current study was to analyze the risk of slippage and to present the evolving technique by adding gastro-gastric plication of the gastric wall covering the BariClip at those areas where the gastric wall "slips" between the limbs of the clip. Methods: All patients undergoing LBCG with the evolving technique of gastric plication around the device associated with antral gastroplasty from January 2021 to May 2022 were included in the study group (group A). A control group (group B) was designed with patients who underwent previous LBCG technique between May 2017 and June 2019. This is a case-controlled group with patients matched by gender and BMI. We have analyzed the postoperative complications and more notably the slippage. Results: One hundred seventy-six patients (44 male and 132 female) with a mean age of 33 years (± 11) underwent evolving technique of LBCG. A control group of 67 patients who underwent previous technique of LBCG was included. All procedures were completed by laparoscopy with no intraoperative complication. For the study group, we have recorded a number of 5 slippages (2.8%). The diagnosis occurred during the first 6 months after the operation. The management consisted of repositioning-3 cases-and BariClip removal-2 cases. For the control group, we have recorded a number of 3 slippages (4.3%). All three patients underwent BariClip removal, with no repositioning. Conclusions: We reported a new technique of placement of the BariClip with additional gastric plication anterior, posterior, and volume reduction in the antrum to potentially reduce the rate of slippage and improve weight loss outcomes.
... All procedures were performed according to Jacobs et al. [9] and the further technical modifications by Noel et al. [14,15]. Patients were placed in a lithotomy position, using four or five laparoscopic ports. ...
... For this same reason, although other sources of hemorrhage certainly exist in LVCG, the hemorrhage rate is expected to be reduced significantly. In fact, there was no such instances in our series, nor was it reported previously [9,14]. Weight regain after SG is most often related to dilatation of the stomach with time. ...
... In other words, it seems that a device-related narrowing of the gastric lumen should allow for a longer-lasting restriction with potentially improved weight loss outcomes. Lateral slippage of the clip may increase the gastric lumen and impair results in terms of weight loss, but this complication appears relatively rare (3-7.7% slippage rate) [9,14]. GERD and Barrett's esophagus may be considered SG's real Achilles' heel, occurring in up to 59% and 16% of SG patients, respectively, needing conversion to RYGB in 4% and representing the indication for 30% of re-do BS after SG [30][31][32][33][34]. ...
Article
Full-text available
PurposeSleeve gastrectomy, the most commonly performed bariatric surgery procedure, carries limitations both short term including postoperative complications such as hemorrhage and gastric fistula and long term such as weight regain and gastroesophageal reflux. A new procedure has been proposed to overcome many of these limitations: laparoscopic vertical clip gastroplasty (LVCG) with BariClip.Materials and Methods Fifty patients were offered LVCG and enrolled for a feasibility study in two referral bariatric centers. Indication was given as for sleeve gastrectomy, after a multidisciplinary path evaluating age, gender, BMI, comorbidities, eating behaviors, and gastroesophageal reflux. The primary outcome was major postoperative complications. Secondary outcomes included weight loss, incidence of de-novo GERD, and comorbidity resolution.ResultsPatients had a mean age of 44 years and mean BMI of 37 kg/m2 ± 6.2. All procedures were performed successfully in laparoscopy, with no conversion or intraoperative adverse events. The overall major postoperative complication rate was 6%. Re-operation was required in three patients for slippage. No mortality occurred. Excess weight loss, excess BMI loss, and total weight loss at 6 months were 36%, 57%, and 22%, respectively. There was no instance of de-novo GERD. Resolution of hypertension occurred in 50% of cases, OSAS in 65% of cases, and DMII in 80% of cases.Conclusion The safety of LVCG procedure has been reproduced in a multicentric, multi-surgeon study. Weight loss outcomes appear promising. A randomized trial is needed to fully assess the benefits of LVCG.Graphical Abstract
... In literature, slippage of BariClip is reported as the main complication related to this surgery (6.0-7.7%) [12,13]. Jacobs et al. in a 39-month pilot study found a slippage rate of 7.7%, while Noel et al. and Gentileschi et al. found a similar slippage rate of 6-6.5%. ...
... Jacobs et al. in a 39-month pilot study found a slippage rate of 7.7%, while Noel et al. and Gentileschi et al. found a similar slippage rate of 6-6.5%. These rates are reported to decrease after the learning curve by these authors [12,13]. ...
Article
Full-text available
Background Laparoscopic BariClip gastroplasty (LBCG) is a new reversible bariatric procedure designed to replicate the restrictive effects of laparoscopic sleeve gastrectomy (LSG) by placing a clip vertically on the stomach. This technique achieves gastric lumen restriction without the need for resection, ensuring organ preservation and reversibility. However, concerns have arisen regarding potential complications such as gastroesophageal reflux disease (GERD), slippage, or erosion of the stomach. The aim of the study is to evaluate the outcomes and complications of LBCG. Methods This is a monocentric retrospective study. We analyzed 149 patients who underwent LBCG procedure between July 2021 and November 2023. A minimum follow-up period of 6 months was observed for all patients, recording clinically relevant GERD through GERD-Q score questionnaires. Weight loss was monitored through body mass index (BMI) and % total weight loss (%TWL), registered during follow-up visits. Results Overall, 149 patients were eligible for this study. Overall complication rate was 8% (12/149). The average BMI went from 40 ± 4.37 kg/m² to 28 ± 4.29 kg/m² (p < 0.05) in 6 months, while the mean %TWL was 22.6% after at least 6 months of follow-up. Clinically relevant GERD went from 18.1% (27/149) to 10.7% (16/149), p = 0.1262. As expected, also the PPI usage was not altered significantly (17.8% vs 16.4%), p = 0.8714. Conclusions LBCG remains an experimental procedure that must be approached with caution. Nonetheless, the potential of LBCG to reproduce the effects of LSG while reducing GERD makes it a promising new reversible option for the treatment of morbid obesity.
... The laparoscopic BariClip gastroplasty (LBCG) is a new reversible gastric sleeve-like procedure without gastrectomy that involves a vertical clip placed parallel to the lesser curvature of the stomach. The first short-term clinical results published have already shown comparable weight loss results to LSG with very few complications and good quality of life for patients [4,5]. Laparoscopic BariClip gastroplasty (LBCG), like other gastric procedures [6,7] using a peri gastric foreign body, can be complicated with slippages. ...
... The BC is made of a titanium skeleton covered with silicone and fixed anteriorly and posteriorly to the stomach silicone with an inferior opening allowing the passage of the gastric juices from the fundus and the body of the stomach into the distal antrum. The BC is placed vertically parallel to the lesser curvature at the same level where a sleeve gastrectomy is usually performed preserving the antrum [4,5]. ...
Article
Full-text available
Introduction Laparoscopic BariClip gastroplasty (LBCG) is a new reversible gastric sleeve-like procedure without gastrectomy proposed to minimize the risk of severe complications. Still one of the possible complications described with LBCG is slippage. The purpose of the current manuscript is to analyze different cases of slippage and propose a classification of this complication. Methods A number of 381 patients who underwent LBCG in 8 different centers were analyzed concerning the risk of slippage. All cases with documented slippage were carefully reviewed in terms of patients’ symptomatology (presence of satiety, vomiting), history of weight loss, radiological data, and management of their slippage. A new classification was proposed depending on the anatomy, the symptomatology, and the time of occurrence. Results We have identified a total of 17 cases (4.46%) of slippage following LBCG. In 11 patients, the slippage was symptomatic with repetitive vomiting and nausea, and in the remaining 6 patients, the slippage was identified by radiological studies for insufficient weight loss, weight regain, or routine radiological follow-up. Depending on the interval time, the slippage was classified as either immediate (in first 7 days) in 6 cases, early (in less than 90 days) in 4 cases, and late (after 3 months) in 7 cases. Evaluation of the radiological studies in these cases identified the following: anterosuperior displacement (type A) in 9 cases, posteroinferior displacement (type B) in 6 cases (one case after 3 months), and lateral displacement (type C) in the remaining 2 cases. The management of the slippage consisted of BariClip removal in 7 cases, repositioning in 5 cases, and conservative treatment in the remaining 5 cases. All patients with conservative treatment were recorded at the beginning of the experience. Conclusions Slippage is a possible complication after LBCG. This classification of the different types of slippage can benefit the surgeon in the management and treatment of this complication of LBCG. Graphical Abstract
... Laparoscopic BariClip gastroplasty (LBCG) could answer the need for a no-resection procedure. LBCG offers a higher restriction than the endoscopic procedures with the advantage of the reversibility by clipping without cutting the stomach; the LBCG procedure almost replicates the effectiveness of the LSG with minimal complications [12,13]. The procedure is performed using a nonadjustable clip that is vertically placed parallel to the lesser curvature. ...
... To overcome these limitations, Jacobs et al. [10] endorsed the Laparoscopic BariClip Gastroplasty as the alternative. In the previous study [13], we reported that LBCG offers an acceptable quality of life with the same principles as LSG and presents several advantages. There is no risk of leak or bleeding, and the LBCG remains a reversible bariatric procedure, and in the case of invalidating GERD, the BariClip can be removed with no complications-allowing, as needed, an antireflux procedure to be performed on a normal stomach. ...
Article
Full-text available
Introduction: Laparoscopic BariClip Gastroplasty (LBCG) represents a new bariatric procedure that mimics the principle of the Laparoscopic Sleeve Gastrectomy (LSG), but using a completely reversible mechanism, which is essential for gastroesophageal reflux disease (GERD). The purpose of our study was to evaluate the evolution of GERD following the initial experience with LBCG. Methods: The first 43 obese patients who underwent LBCG performed by the same surgeon in two different medical centers in May 2018-December 2019 were included in the current study. Twelve patients had issues of reflux, regularly receiving PPIs (proton pump inhibitors) treatment in eight cases, and occasionally in four cases. Thirty-two patients completed the follow-up at one year and the GERD was evaluated using the PPI medications and the GerdQ. Results: The median preoperative GerdQ score was (14.58 ± 1.9). Three patients out of the twelve who had complained about preoperative GERD did not consent to the one year follow-up form. For the rest of nine patients, the median post-operative GerdQ score was (10.11 ± 3.2). The PPIs were used at one year follow-up in six patients: four with occasional use, one patient with regular use showing no improvement, and one who experienced de novo GERD symptomatology (3.1%). No statistically significant difference between the groups was recorded in terms of GERD. We recorded no intraoperative complications. No case of erosion occurred in the post-operative period, but we encountered two cases of slippage. One additional BariClip was removed at 14 months. Conclusion: LBCG represents a new bariatric procedure that mimics the principle of the laparoscopic sleeve gastrectomy, but with a completely reversible mechanism. Even with limited cases, our experience reports several mechanisms of action that will be evaluated and discussed in further prospective clinical trials. After this preliminary clinical study, LBCG's effects on GERD and its safety are highly encouraging.
... Subsequently, a device with similar principle, the vertical gastric clip (Jacobs et al., 2017;Noel et al., 2018) or BariClip (Noel et al., 2020), was used in patients. Parallel to the lesser curvature, the device separates a medial lumen from an excluded lateral gastric pouch (Jacobs et al., 2017). ...
... The reduction of BMI and % excess weight loss were 12.7 and 66.7, respectively, at 2 years after the operation (Jacobs et al., 2017). In addition, the quality of life was improved in more than 90% of patients (Noel et al., 2018). A simpler device named Gastric Clip (Chao et al., 2019) was also used in clinics. ...
Article
Full-text available
Obesity is a chronic disease that affects over 795 million people worldwide. Bariatric surgery is an effective therapy to combat the epidemic of clinically severe obesity, but it is only performed in a very small proportion of patients because of the limited surgical indications, the irreversibility of the procedure, and the potential postoperative complications. As an alternative to bariatric surgery, numerous medical devices have been developed for the treatment of morbid obesity and obesity-related disorders. Most devices target restriction of the stomach, but the mechanism of action is likely more than just mechanical restriction. The objective of this review is to integrate the underlying mechanisms of gastric restrictive bariatric devices in obesity and comorbidities. We call attention to the need for future studies on potential mechanisms to shed light on how current gastric volume-restriction bariatric devices function and how future devices and treatments can be further improved to combat the epidemic of obesity.
... BariClip gastroplasty is indicated for patients seeking a restrictive and reversible bariatric procedure with reduced surgical trauma and potentially lower major complication rates compared to sleeve gastrectomy (SG). Initial short-term clinical results have shown comparable weight loss results to LSG with few complications and improved quality of life (QoL) [1,[3][4][5][6]. However, clip slippage can occur in 4 to 8% of cases with subsequent risk of occlusion and perforation [7]. ...
... To overcome LSG's limitations, a promising bariatric procedure has been proposed: laparoscopic vertical clip gastroplasty (LVCG) using the BariClip device, which follows principles of LSG, but may have fewer associated risks and improved long-term results. The procedure, characterised by a completely reversible mechanism, consists of a nonadjustable clip that is vertically placed parallel to the lesser curvature of the stomach, separating the stomach in a medial restricted alimentary segment and a lateral excluded segment, effectively mimicking LSG, without requiring stapling, resection, or change in anatomy [3][4][5]. ...
Article
Full-text available
Background: Laparoscopic sleeve gastrectomy (SG) has become the most frequently performed bariatric procedure worldwide. De novo reflux might impact patients' quality of life, requiring lifelong proton pump inhibitor medication. It also increases the risk of esophagitis and formation of Barrett's metaplasia. Besides weight regain, gastroesophageal reflux disease (GERD) is the most common reason for conversion to Roux-en-Y gastric bypass. Methods: We performed 24-h pH metries, manometries, gastroscopies, and questionnaires focusing on reflux (GIQLI, RSI) in SG patients with a follow-up of more than 10 years who did not suffer from symptomatic reflux or hiatal hernia preoperatively. Results: From a total of 53 patients, ten patients after adjustable gastric banding were excluded. From the remaining 43, six patients (14.0%) were converted to RYGB due to intractable reflux over a period of 130 months. Ten out of the remaining non-converted patients (n = 26) also suffered from symptomatic reflux. Gastroscopies revealed de novo hiatal hernias in 45% of the patients and Barrett's metaplasia in 15%. SG patients suffering from symptomatic reflux scored significantly higher in the RSI (p = 0.04) and significantly lower in the GIQLI (p = 0.02) questionnaire. Conclusions: This study shows a high incidence of Barrett's esophagus and hiatal hernias at more than 10 years after SG. Its results therefore suggest maintaining pre-existing large hiatal hernia, GERD, and Barrett's esophagus as relative contraindications to SG. The limitations of this study-its small sample size as well as the fact that it was based on early experience with SG-make drawing any general conclusions about this procedure difficult.
Article
Full-text available
Laparoscopic sleeve gastrectomy (LSG) has reached wide popularity during the last 15 years, due to the limited morbidity and mortality rates, and the very good weight loss results and effects on comorbid conditions. However, there are concerns regarding the effects of LSG on gastroesophageal reflux disease (GERD). The interpretation of the current evidence is challenged by the fact that the LSG technique is not standardized, and most studies investigate the presence of GERD by assessing symptoms and the use of acid reducing medications only. A few studies objectively investigated gastroesophageal function and the reflux profile by esophageal manometry and 24-h pH monitoring, reporting postoperative normalization of esophageal acid exposure in up to 85% of patients with preoperative GERD, and occurrence of de novo GERD in about 5% of cases. There is increasing evidence showing the key role of the surgical technique on the incidence of postoperative GERD. Main technical issues are a relative narrowing of the mid portion of the gastric sleeve, a redundant upper part of the sleeve (both depending on the angle under which the sleeve is stapled), and the presence of a hiatal hernia. Concomitant hiatal hernia repair is recommended. To date, either medical therapy with proton pump inhibitors or conversion of LSG to laparoscopic Rouxen- Y gastric bypass are the available options for the management of GERD after LSG. Recently, new minimally invasive approaches have been proposed in patients with GERD and hypotensive LES: the LINX® Reflux Management System procedure and the Stretta ® procedure. Large studies are needed to assess the safety and long-term efficacy of these new approaches. In conclusion, the recent publication of pH monitoring data and the new insights in the association between sleeve morphology and GERD control have led to a wider acceptance of LSG as bariatric procedure also in obese patients with GERD, as recently stated in the 5th International Consensus Conference on sleeve gastrectomy. © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article
Full-text available
Background Laparoscopic sleeve gastrectomy (LSG) became the most frequent bariatric procedure performed in France (2011) and in the United States (2013), but studies reporting long-term results are still rare. Setting Private hospital, France. Methods This is a retrospective analysis of a prospective cohort of 168 patients who underwent LSG between 2005 and 2008. The objective of this study was to present the 8-year outcome concerning weight loss, modification of co-morbidities, and to report the revisional surgery after sleeve. Results The preoperative mean body mass index was 42.8 kg/m2 (31.1–77.9), 35 patients were super obese, and 64 patients had a previous gastric band. For LSG as a definitive bariatric procedure, 8 years of follow-up data were available for 116 patients (follow-up: 69%). Of the remainder, 23 patients underwent revisional surgery and 29 were lost to follow-up. For the entire cohort, the mean excess weight loss (EWL) was 76% (0–149) at 5 years and 67% (4–135) at 8 years, respectively. Of the 116 patients with 8 years of follow-up, 82 patients had>50% EWL at 8 years (70.7%). Percentages of co-morbidities resolved were hypertension, 59.4%; type 2 diabetes, 43.4%; and obstructive sleep apnea, 72.4%. Twenty-three patients had revisional surgery for weight regain (n = 14) or for severe reflux (n = 9) at a mean period of 50 months (9–96). Twelve patients underwent resleeve gastrectomy, 6 patients underwent conversion to a bypass, and 5 patients to duodenal switch (1 single anastomosis duodeno-ileostomy). A total of 31% of patients reported gastroesophageal reflux symptoms at 8 years. Conclusions At 8 years postoperatively, the LSG as a definitive bariatric procedure remained effective for 59% of cases. The results appear to be more favorable especially for the non-super-obese patients and primary procedures. LSG is a well-tolerated bariatric procedure with low long-term complication rates.
Article
Full-text available
Background Morbidly obese patients are affected by gastroesophageal reflux disease (GERD) and hiatal hernia (HH) more frequently than lean patients. Because of conflicting results, the indication to sleeve gastrectomy (SG) in patients with GERD is still debated. Objectives To evaluate the incidence of GERD on the basis of clinical, endoscopic, and histologic data in patients undergoing SG. Settings University hospital, Rome, Italy. Methods From July 2007 to January 2010, 162 patients underwent primary SG. Preoperatively all patients underwent visual analogue scale (VAS) evaluation of GERD symptoms, proton pump inhibitors (PPIs) consumption recording, and esophagogastroduodenoscopy (EGD). Stomach resection started 6 cm from pylorus on a 48Fr bougie. Staple line was reinforced by an oversewing suture. A postoperative clinical control with VAS evaluation, PPI consumption, and EGD was proposed to all patients. Three patients were excluded because of the occurrence of major postoperative complications. Results A total of 110 patients accepted to take part in the study (follow-up rate: 69.1%). At a mean 58 months of follow-up, incidence of GERD symptoms, VAS mean score, and PPI intake significantly increased compared with preoperative values (68.1% versus 33.6%: P<.0001; 3 versus 1.8: P = .018; 57.2% versus 19.1%: P<.0001) At EGD, an upward migration of the “Z” line and a biliary-like esophageal reflux was found in 73.6% and 74.5% of cases, respectively. A significant increase in the incidence and in the severity of erosive esophagitis (EE) was evidenced, whereas nondysplastic Barrett’s esophagus (BE) was newly diagnosed in 19 patients (17.2%). No significant correlations were found between GERD symptoms and endoscopic findings. Conclusion In the present series the incidence of EE and of BE in SG patients was considerably higher than that reported in the current literature, and it was not related to GERD symptoms. Endoscopic surveillance after SG should be advocated irrespective of the presence of GERD symptoms.
Article
Full-text available
Background: Morbid obesity remains one of society's significant medical dilemmas. It is rapidly worsening and expected to affect 35% of the US population by the year 2020. Common current bariatric procedures exist and include, but not limited to, the adjustable gastric band, gastric bypass, and the sleeve gastrectomy. Although beneficial to morbidly obese patients, they also alter the patient's anatomy and involve resections, or require maintenance. The goal of the trial is to show a new minimally invasive vertical gastric clip technique that produces significant weight loss but requires no resection, no change in anatomy, and is reversible. Methods: From November 2012 to February 2016, prospective collected data from 117 patients was included in the gastric clip trial. The clip consists of a silicone-covered titanium backbone with an inferior hinged opening that separates a medial lumen from an excluded lateral gastric pouch. The inferior opening allows the gastric juices to empty from the fundus and the body of the stomach into the distal antrum. Results: Weight loss and comorbidities were evaluated among 117 patients over a 39-month period. 66.7% excess weight loss was seen with minimal adverse events. Average length of surgery was 69 min. Average length of stay was 1.3 days. Fifteen of the originally implanted clips were electively removed based on the original protocol, and the other two were removed for displacement of the device. Conclusion: The vertical, gastric clip trial has shown that excellent weight loss can be achieved without some of the complications seen with historical bariatric procedures. This clip is placed without requiring stapling, resection, malabsorption, change in anatomy, or maintenance. It is also easily reversible.
Article
Full-text available
Background: Sleeve gastrectomy (SG) is one of the most frequently performed bariatric procedures worldwide. Despite its impressive results, there is a growing concern about the relationship between SG and gastroesophageal reflux disease (GERD). Objectives: We present our pilot study of patients operated with a Nissen anti-reflux valve added to a standard SG. Setting: University hospital in Montpellier, France. Methods: A prospective monocentric study including 25 consecutive patients operated with a laparoscopic Nissen-Sleeve (N-Sleeve) gastrectomy was carried out between September 2013 and March 2014. Inclusion criteria were indication for bariatric surgery for patients with GERD (Montreal's definition and classification). All patients were followed postoperatively for 1 year. Results: There were 13 (54%) females and 12 (46%) males with mean age of 41±12 (20-65) years. Mean body mass index was 42±4.8 (35-53) kg/m(2). Preoperatively, all patients had esophageal syndromes. Twenty-three (92%) patients had typical symptoms of GERD, but 2 were asymptomatic; however, they had esophageal injury. Esophagitis grade I-III presented in 10 (40%) patients and Barrett's esophagus in 8 (32%) cases. Two (8%) patients also had extraesophageal syndrome represented by asthma. Nineteen (76%) patients previously took proton pump inhibitors, regularly and 22 (88%) had experienced a hiatal hernia. There was no conversion to the open technique. Operative time was 84±13 (54-106) minutes. There were no deaths. Complications included one case of staple line bleeding and one Nissen valve perforation without recognized ischemia. No staple line failure was observed. Three months after N-Sleeve, 19 (76%) patients remained asymptomatic without proton pump inhibitor use. At 6 months and 1 year, 3 (12%) patients were still experiencing reflux. Excess weight loss at 1 year was 58±23%, total weight loss was 27±10%, and body mass index change was -11±4 kg/m². Conclusion: The N-Sleeve seems to be a safe procedure that provides an adequate reflux control with no clear interference on the expected bariatric results of a standard SG.
Article
Full-text available
Laparoscopic sleeve gastrectomy (LSG) has gained significant popularity in the USA, and consequently resulted in patients experiencing new-onset gastroesophageal reflux disease (GERD) following this bariatric procedure. Patients with GERD refractory to medical therapy present a more challenging situation limiting the surgical options to further treat the de novo GERD symptoms since the gastric fundus to perform a fundoplication is no longer an option. The aim of this study is to determine if the LINX® magnetic sphincter augmentation system is a safe and effective option for patients with new gastroesophageal reflux disease following laparoscopic sleeve gastrectomy. This study was conducted at the University Medical Center. This is a retrospective review of seven consecutive patients who had a laparoscopic LINX® magnetic sphincter device placement for patients with refractory gastroesophageal reflux disease after laparoscopic sleeve gastrectomy between July 2014 and April 2015. All patients were noted to have self-reported greatly improved gastroesophageal reflux symptoms 2-4 weeks after their procedure. They were all noted to have statistically significant improved severity and frequency of their reflux, regurgitation, epigastric pain, sensation of fullness, dysphagia, and cough symptoms in their postoperative GERD symptoms compared with their preoperative evaluation. This is the first reported pilot case series, illustrating that the LINX® device is a safe and effective option in patients with de novo refractory gastroesophageal reflux disease after a laparoscopic sleeve gastrectomy despite appropriate weight loss.